Article info

Download PDFPDF
Concise Report
An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's)

Authors

  1. Correspondence to Dr Carol A Langford, Center for Vasculitis Care and Research, Cleveland Clinic, 9500 Euclid Avenue, A50 Cleveland, OH 44195, USA; langfoc{at}ccf.org
View Full Text

Citation

Langford CA, Monach PA, Specks U, et al
An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's)

Publication history

  • Received June 22, 2013
  • Revised September 5, 2013
  • Accepted November 5, 2013
  • First published December 9, 2013.
Online issue publication 
June 06, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.